<!DOCTYPE html>
<html lang="en" dir="ltr">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="manifest" href="/manifest.json">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">

  <!-- SEO -->
  <title>Acute Myeloid Leukemia (AML) ‚Äî Comprehensive Guide | StopMyCancer</title>
  <meta name="description" content="Evidence-based AML guide. Types, cytogenetics, risk factors, symptoms, diagnosis, staging, treatment with chemotherapy and targeted therapy. Explained without jargon.">
  <meta name="keywords" content="acute myeloid leukemia, AML, AML treatment, daunorubicin, cytarabine, FLT3, NPM1, TP53, AML remission, FLT3 inhibitor, IDH inhibitor, venetoclax">
  <meta name="author" content="StopMyCancer">
  <link rel="canonical" href="https://stopmycancer.com/cancers/aml/">
  <meta name="robots" content="index, follow">

  <!-- Open Graph -->
  <meta property="og:type" content="article">
  <meta property="og:title" content="Acute Myeloid Leukemia (AML) ‚Äî Comprehensive Guide | StopMyCancer">
  <meta property="og:description" content="Plain-language AML guide. Types, risk factors, treatment, and questions to ask your doctor.">
  <meta property="og:url" content="https://stopmycancer.com/cancers/aml/">
  <meta property="og:site_name" content="StopMyCancer">
  <meta property="og:image" content="https://images.unsplash.com/photo-1576091160550-2173dba999ef?w=1200&h=630&fit=crop&q=80">

  <!-- Structured Data ‚Äî MedicalCondition -->
  <script type="application/ld+json">
  {
    "@context": "https://schema.org",
    "@type": "MedicalCondition",
    "name": "Acute Myeloid Leukemia",
    "alternateName": ["AML", "Acute Myelogenous Leukemia"],
    "description": "AML is a rapidly progressing blood cancer where bone marrow produces too many immature myeloid cells. Requires urgent treatment but has improved prognosis with modern therapies and targeted approaches.",
    "url": "https://stopmycancer.com/cancers/aml/",
    "code": {
      "@type": "MedicalCode",
      "codeValue": "C92.0",
      "codingSystem": "ICD-10"
    },
    "riskFactor": [
      {"@type": "MedicalRiskFactor", "name": "Age over 65"},
      {"@type": "MedicalRiskFactor", "name": "Prior chemotherapy or radiation"},
      {"@type": "MedicalRiskFactor", "name": "Myelodysplastic syndrome (MDS)"},
      {"@type": "MedicalRiskFactor", "name": "Smoking"}
    ],
    "signOrSymptom": [
      {"@type": "MedicalSignOrSymptom", "name": "Fatigue"},
      {"@type": "MedicalSignOrSymptom", "name": "Fever"},
      {"@type": "MedicalSignOrSymptom", "name": "Easy bruising or bleeding"},
      {"@type": "MedicalSignOrSymptom", "name": "Shortness of breath"}
    ],
    "possibleTreatment": [
      {"@type": "MedicalTherapy", "name": "Intensive chemotherapy"},
      {"@type": "MedicalTherapy", "name": "Hypomethylating agents"},
      {"@type": "MedicalTherapy", "name": "Targeted therapy"},
      {"@type": "MedicalTherapy", "name": "Stem cell transplantation"},
      {"@type": "MedicalTherapy", "name": "Venetoclax"}
    ],
    "epidemiology": "Approximately 20,000 new cases annually in the United States. Most common acute leukemia in adults."
  }
  </script>

  <!-- Breadcrumb -->
  <script type="application/ld+json">
  {
    "@context": "https://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
      {"@type": "ListItem", "position": 1, "name": "Home", "item": "https://stopmycancer.com/"},
      {"@type": "ListItem", "position": 2, "name": "Cancer Types", "item": "https://stopmycancer.com/cancers/"},
      {"@type": "ListItem", "position": 3, "name": "Acute Myeloid Leukemia", "item": "https://stopmycancer.com/cancers/aml/"}
    ]
  }
  </script>

  <!-- Hreflang -->
  <link rel="alternate" hreflang="en" href="https://stopmycancer.com/cancers/aml/">
  <link rel="alternate" hreflang="es" href="https://stopmycancer.com/es/cancers/aml/">
  <link rel="alternate" hreflang="fr" href="https://stopmycancer.com/fr/cancers/aml/">
  <link rel="alternate" hreflang="x-default" href="https://stopmycancer.com/cancers/aml/">

  <!-- Fonts -->
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
  <link rel="preconnect" href="https://images.unsplash.com">

  <!-- Stylesheet -->
  <link rel="stylesheet" href="/css/styles.css">

  <!-- Favicon -->
  <link rel="icon" type="image/svg+xml" href="data:image/svg+xml,<svg xmlns='http://www.w3.org/2000/svg' viewBox='0 0 100 100'><text y='.9em' font-size='90'>üõ°Ô∏è</text></svg>">
</head>
<body>

  <!-- Skip Link -->
  <a href="#main" class="skip-link">Skip to main content</a>

  <!-- Header -->
  <header class="header" role="banner">
    <div class="header__inner">
      <a href="/" class="header__logo" aria-label="StopMyCancer Home">
        <div class="header__logo-icon" aria-hidden="true">S</div>
        Stop<span>My</span>Cancer
      </a>

      <nav class="header__nav" role="navigation" aria-label="Main navigation">
        <a href="/cancers/" class="header__nav-link header__nav-link--active">Cancer Types</a>
        <a href="/navigate/" class="header__nav-link">Navigate</a>
        <a href="/stories/" class="header__nav-link">Stories</a>
        <a href="/access/" class="header__nav-link">Access &amp; Equity</a>
        <a href="/tools/pathology-translator" class="header__nav-link">Translator Tool</a>
        <a href="/about/" class="header__nav-link">About</a>
      </nav>

      <div class="header__actions">
        <div class="lang-switcher">
          <button class="lang-switcher__btn" aria-haspopup="true" aria-expanded="false" aria-label="Change language">
            <svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><circle cx="12" cy="12" r="10"></circle><line x1="2" y1="12" x2="22" y2="12"></line><path d="M12 2a15.3 15.3 0 0 1 4 10 15.3 15.3 0 0 1-4 10 15.3 15.3 0 0 1-4-10 15.3 15.3 0 0 1 4-10z"></path></svg>
            EN
            <svg width="12" height="12" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M6 9l6 6 6-6"></path></svg>
          </button>
          <div class="lang-switcher__dropdown" role="menu">
            <a href="/cancers/aml/" class="lang-switcher__option lang-switcher__option--active" role="menuitem">English</a>
            <a href="/es/cancers/aml/" class="lang-switcher__option" role="menuitem">Espa√±ol</a>
            <a href="/fr/cancers/aml/" class="lang-switcher__option" role="menuitem">Fran√ßais</a>
          </div>
        </div>

        <button class="mobile-toggle" aria-label="Open menu" aria-expanded="false" aria-controls="mobile-nav">
          <span class="mobile-toggle__line"></span>
          <span class="mobile-toggle__line"></span>
          <span class="mobile-toggle__line"></span>
        </button>
      </div>
    </div>
  </header>

  <!-- Mobile Navigation -->
  <nav class="mobile-nav" id="mobile-nav" role="navigation" aria-label="Mobile navigation">
    <a href="/cancers/" class="mobile-nav__link">Cancer Types</a>
    <a href="/navigate/" class="mobile-nav__link">Navigate</a>
    <a href="/stories/" class="mobile-nav__link">Stories</a>
    <a href="/access/" class="mobile-nav__link">Access &amp; Equity</a>
    <a href="/tools/pathology-translator" class="mobile-nav__link">Pathology Translator</a>
    <a href="/about/" class="mobile-nav__link">About</a>
    <div class="mobile-nav__lang">
      <div class="mobile-nav__lang-title">Language</div>
      <div class="mobile-nav__lang-options">
        <a href="/cancers/aml/" class="mobile-nav__lang-btn mobile-nav__lang-btn--active">EN</a>
        <a href="/es/cancers/aml/" class="mobile-nav__lang-btn">ES</a>
        <a href="/fr/cancers/aml/" class="mobile-nav__lang-btn">FR</a>
      </div>
    </div>
  </nav>

  <main id="main">

    <section class="section" style="padding-bottom: 0;">
      <div class="container">
        <nav class="breadcrumb fade-in" aria-label="Breadcrumb">
          <a href="/">Home</a>
          <span class="breadcrumb__sep" aria-hidden="true">/</span>
          <a href="/cancers/">Cancer Types</a>
          <span class="breadcrumb__sep" aria-hidden="true">/</span>
          <span aria-current="page">Acute Myeloid Leukemia (AML)</span>
        </nav>
      </div>
    </section>

    <section class="page-header">
      <div class="container">
        <div class="fade-in">
          <span class="page-header__label">Medical Encyclopedia</span>
          <h1 class="page-header__title">Acute Myeloid Leukemia (AML)</h1>
          <p class="page-header__desc">
            A blood cancer requiring urgent treatment but with improved prognosis thanks to modern therapies. This guide explains types, risk factors, symptoms, diagnosis, and treatment strategies.
          </p>
        </div>
        <div class="page-header__image fade-in" style="transition-delay: 0.15s;">
          <img src="https://images.unsplash.com/photo-1576091160550-2173dba999ef?w=1200&h=400&fit=crop&q=80" alt="Medical researcher working in a clinical laboratory" loading="eager" width="1200" height="400">
        </div>
      </div>
    </section>

    <section class="section" style="padding-top: 0; padding-bottom: var(--space-xl);">
      <div class="container">
        <div class="safety-banner fade-in">
          <svg class="safety-banner__icon" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M10.29 3.86L1.82 18a2 2 0 0 0 1.71 3h16.94a2 2 0 0 0 1.71-3L13.71 3.86a2 2 0 0 0-3.42 0z"></path><line x1="12" y1="9" x2="12" y2="13"></line><line x1="12" y1="17" x2="12.01" y2="17"></line></svg>
          <div class="safety-banner__text">
            <strong>Not medical advice.</strong> AML requires urgent treatment. If you have symptoms like unexplained fever, severe fatigue, or unusual bleeding, <strong>seek immediate medical care</strong>.
          </div>
        </div>
      </div>
    </section>

    <section class="section section--alt" id="overview">
      <div class="container">
        <div class="section__header fade-in">
          <span class="section__label">At a Glance</span>
          <h2 class="section__title">Quick Overview</h2>
        </div>
        <div class="card-grid fade-in" style="transition-delay: 0.1s;">
          <div class="card">
            <div class="card__body" style="text-align: center; padding: var(--space-2xl);">
              <div class="card__icon card__icon--primary" style="margin: 0 auto var(--space-md); font-size: 24px; width: 56px; height: 56px;">
                <span aria-hidden="true">~20K</span>
              </div>
              <h3 class="card__title">Annual Incidence</h3>
              <p class="card__desc">Approximately 20,000 new cases per year in the United States. Most common acute leukemia in adults. <a href="#references">[ACS, 2024]</a></p>
            </div>
          </div>
          <div class="card">
            <div class="card__body" style="text-align: center; padding: var(--space-2xl);">
              <div class="card__icon card__icon--secondary" style="margin: 0 auto var(--space-md); font-size: 24px; width: 56px; height: 56px;">
                <span aria-hidden="true">Urgent</span>
              </div>
              <h3 class="card__title">Requires Urgent Treatment</h3>
              <p class="card__desc">AML is a rapidly progressive disease. Diagnosis requires immediate treatment initiation, typically within days. <a href="#references">[NCI, 2024]</a></p>
            </div>
          </div>
          <div class="card">
            <div class="card__body" style="text-align: center; padding: var(--space-2xl);">
              <div class="card__icon card__icon--accent" style="margin: 0 auto var(--space-md); font-size: 24px; width: 56px; height: 56px;">
                <span aria-hidden="true">Age</span>
              </div>
              <h3 class="card__title">Median Age at Diagnosis: 68</h3>
              <p class="card__desc">Most common in older adults, though can occur at any age. Treatment approach varies based on age and fitness. <a href="#references">[ACS, 2024]</a></p>
            </div>
          </div>
          <div class="card">
            <div class="card__body" style="text-align: center; padding: var(--space-2xl);">
              <div class="card__icon card__icon--info" style="margin: 0 auto var(--space-md); font-size: 24px; width: 56px; height: 56px;">
                <span aria-hidden="true">CR%</span>
              </div>
              <h3 class="card__title">Complete Remission Possible</h3>
              <p class="card__desc">50-80% of patients achieve complete remission with modern treatment. Survival rates have improved significantly. <a href="#references">[NCCN, 2024]</a></p>
            </div>
          </div>
        </div>
      </div>
    </section>

    <section class="section" id="what-is">
      <div class="container">
        <div class="section__header fade-in">
          <span class="section__label">Understanding the Basics</span>
          <h2 class="section__title">What Is Acute Myeloid Leukemia?</h2>
        </div>
        <div class="prose fade-in" style="transition-delay: 0.1s;">
          <p>
            AML is a blood cancer where the bone marrow produces too many immature myeloid cells (blasts), overwhelming normal blood cell production. This leads to anemia (low red cells), infections (low white cells), and bleeding problems (low platelets). Unlike slowly progressive diseases, AML is fast-moving and requires prompt treatment. However, modern therapies offer much better outcomes than in the past, with many patients achieving long-term remission. <a href="#references">[NCI, 2024]</a>
          </p>
          <p>
            The key to AML management is understanding your cytogenetic and molecular profile ‚Äî the specific genetic mutations in your leukemic cells ‚Äî because this determines prognosis and guides treatment selection.
          </p>
        </div>
      </div>
    </section>

    <section class="section section--alt" id="types">
      <div class="container">
        <div class="section__header fade-in">
          <span class="section__label">Classification</span>
          <h2 class="section__title">AML Types &amp; Genetics</h2>
        </div>
        <div class="card-grid fade-in" style="transition-delay: 0.1s;">
          <div class="card">
            <div class="card__body" style="padding: var(--space-2xl);">
              <h3 class="card__title">Cytogenetic Categories</h3>
              <p class="card__desc">
                AML is classified by chromosome patterns. Favorable cytogenetics (translocations like t(15;17), t(8;21)) have better prognosis. Unfavorable cytogenetics (complex karyotype, -5, -7, TP53 mutations) require more intensive treatment. <a href="#references">[NCCN, 2024]</a>
              </p>
            </div>
          </div>
          <div class="card">
            <div class="card__body" style="padding: var(--space-2xl);">
              <h3 class="card__title">Molecular Mutations</h3>
              <p class="card__desc">
                Testing for mutations (FLT3, NPM1, IDH1, IDH2, TP53, etc.) guides prognosis and treatment selection. Some mutations respond to targeted therapy. Mutation profiling is now standard for all AML. <a href="#references">[ACS, 2024]</a>
              </p>
            </div>
          </div>
          <div class="card">
            <div class="card__body" style="padding: var(--space-2xl);">
              <h3 class="card__title">Treatment-Related AML</h3>
              <p class="card__desc">
                AML that develops after prior chemotherapy or radiation (secondary AML) has worse prognosis and different treatment options, often hypomethylating agents rather than intensive chemotherapy. <a href="#references">[NCI, 2024]</a>
              </p>
            </div>
          </div>
          <div class="card">
            <div class="card__body" style="padding: var(--space-2xl);">
              <h3 class="card__title">APL (Acute Promyelocytic Leukemia)</h3>
              <p class="card__desc">
                A specific AML subtype with t(15;17) translocation. Highly curable with targeted treatment (ATRA and arsenic trioxide), with cure rates exceeding 80%. Rapid diagnosis and treatment are critical. <a href="#references">[ACS, 2024]</a>
              </p>
            </div>
          </div>
        </div>
      </div>
    </section>

    <section class="section" id="diagnosis">
      <div class="container">
        <div class="section__header fade-in">
          <span class="section__label">Finding the Answer</span>
          <h2 class="section__title">Diagnosis &amp; Testing</h2>
        </div>
        <div class="prose fade-in" style="transition-delay: 0.1s;">
          <h3>Blood Tests &amp; CBC</h3>
          <p>Initial blood work shows elevated blast count (immature cells), anemia, low white count, and low platelets. <a href="#references">[NCI, 2024]</a></p>

          <h3>Bone Marrow Biopsy &amp; Aspirate</h3>
          <p>Definitive diagnosis requires bone marrow sample showing 20%+ blasts. Samples are sent for cytochemistry, flow cytometry, cytogenetics, and molecular testing. <a href="#references">[ACS, 2024]</a></p>

          <h3>Cytogenetics &amp; Molecular Testing</h3>
          <p>Chromosome analysis, fluorescence in situ hybridization (FISH), and DNA mutation testing determine prognosis and treatment eligibility. Essential for all AML patients. <a href="#references">[NCCN, 2024]</a></p>

          <h3>Imaging</h3>
          <p>CT or MRI may assess organ involvement. Lumbar puncture checks for leukemia in the central nervous system. <a href="#references">[NCI, 2024]</a></p>
        </div>
      </div>
    </section>

    <section class="section section--alt" id="treatment">
      <div class="container">
        <div class="section__header fade-in">
          <span class="section__label">Your Treatment</span>
          <h2 class="section__title">AML Treatment Approaches</h2>
        </div>
        <div class="prose fade-in" style="transition-delay: 0.1s;">

          <h3>Intensive Chemotherapy (Induction)</h3>
          <p>
            Standard regimen is "7+3" (cytarabine for 7 days + daunorubicin for 3 days). Goal is complete remission (CR). Recovery typically takes 3-4 weeks. Intensive therapy is standard for younger, fit patients. <a href="#references">[NCCN, 2024]</a>
          </p>

          <h3>Hypomethylating Agents</h3>
          <p>
            Azacitidine or decitabine are often used in older or unfit patients, given as outpatient therapy. May take months to achieve response but have fewer side effects than intensive chemotherapy. <a href="#references">[ACS, 2024]</a>
          </p>

          <h3>Targeted Therapy</h3>
          <p>
            FLT3 inhibitors (for FLT3-mutant AML), IDH inhibitors (for IDH1/2-mutant AML), and venetoclax (often combined with hypomethylating agents) offer personalized treatment based on mutations. <a href="#references">[NCI, 2024]</a>
          </p>

          <h3>Consolidation &amp; Stem Cell Transplantation</h3>
          <p>
            After achieving remission, consolidation chemotherapy or stem cell transplant helps prevent relapse. Transplantation considered for high-risk disease or after first relapse. <a href="#references">[NCCN, 2024]</a>
          </p>

          <h3>Supportive Care</h3>
          <p>
            Antibiotics, blood transfusions, and platelet support are essential during treatment. Infection prevention and management are critical. <a href="#references">[ACS, 2024]</a>
          </p>
        </div>
      </div>
    </section>

    <section class="section" id="side-effects">
      <div class="container">
        <div class="section__header fade-in">
          <span class="section__label">Challenges of Treatment</span>
          <h2 class="section__title">Side Effects &amp; Complications</h2>
        </div>
        <div class="card-grid fade-in" style="transition-delay: 0.1s;">
          <div class="card">
            <div class="card__body" style="padding: var(--space-2xl);">
              <h3 class="card__title">Infection Risk</h3>
              <p class="card__desc">Severe immunosuppression during chemotherapy creates infection risk. Prophylactic antibiotics and careful monitoring are standard. Fever warrants immediate medical attention.</p>
            </div>
          </div>
          <div class="card">
            <div class="card__body" style="padding: var(--space-2xl);">
              <h3 class="card__title">Chemotherapy Toxicity</h3>
              <p class="card__desc">Nausea, mouth sores, hair loss, diarrhea, and organ damage (cardiac, renal, hepatic) can occur. Supportive medications help manage symptoms.</p>
            </div>
          </div>
          <div class="card">
            <div class="card__body" style="padding: var(--space-2xl);">
              <h3 class="card__title">Fatigue &amp; Anemia</h3>
              <p class="card__desc">Severe fatigue is universal during treatment. Blood transfusions support red cell counts. Fatigue typically improves with remission.</p>
            </div>
          </div>
          <div class="card">
            <div class="card__body" style="padding: var(--space-2xl);">
              <h3 class="card__title">Emotional &amp; Psychological Toll</h3>
              <p class="card__desc">AML diagnosis is devastating. Fear, anxiety, and depression are common. Counseling and support groups are important resources.</p>
            </div>
          </div>
        </div>
      </div>
    </section>

    <section class="section section--alt" id="references">
      <div class="container">
        <div class="section__header fade-in">
          <span class="section__label">Evidence Base</span>
          <h2 class="section__title">Sources &amp; References</h2>
        </div>
        <div class="prose fade-in" style="transition-delay: 0.1s;">
          <ol>
            <li><strong>American Cancer Society (ACS).</strong> "Acute Myeloid Leukemia Overview." Cancer.org. Accessed 2024.</li>
            <li><strong>National Cancer Institute (NCI).</strong> "Acute Myeloid Leukemia Treatment (PDQ)." Cancer.gov. Accessed 2024.</li>
            <li><strong>National Comprehensive Cancer Network (NCCN).</strong> "NCCN Guidelines: Acute Myeloid Leukemia." Version 1.2024.</li>
          </ol>
          <p style="margin-top: var(--space-xl); color: var(--color-text-muted); font-size: var(--text-sm);">
            <strong>Last reviewed:</strong> February 2025. Not medical advice. Always consult your care team.
          </p>
        </div>
      </div>
    </section>

  </main>

  <!-- FOOTER -->
  <footer class="footer" role="contentinfo">
    <div class="container">
      <div class="footer__grid">
        <div class="footer__brand">
          <div class="footer__logo">Stop<span>My</span>Cancer</div>
          <p class="footer__tagline">Your cancer. Explained. Supported. Navigated. A clinically-grounded, plain-language cancer guide. Free, global, and female-first.</p>
        </div>
        <div>
          <h4 class="footer__col-title">Learn</h4>
          <a href="/cancers/" class="footer__link">Cancer Types</a>
          <a href="/navigate/" class="footer__link">Navigation Guides</a>
        </div>
        <div>
          <h4 class="footer__col-title">Tools</h4>
          <a href="/tools/pathology-translator" class="footer__link">Pathology Translator</a>
        </div>
        <div>
          <h4 class="footer__col-title">About</h4>
          <a href="/about/" class="footer__link">Our Mission</a>
        </div>
      </div>
      <div class="footer__bottom">
        <p class="footer__copyright">&copy; 2025 StopMyCancer.com. Not medical advice.</p>
        <div class="footer__legal">
          <a href="/es/" class="footer__legal-link">Espa√±ol</a>
          <a href="/fr/" class="footer__legal-link">Fran√ßais</a>
        </div>
      </div>
    </div>
  </footer>

  <!-- Scripts -->
  <script src="/js/main.js"></script>
</body>
</html>
